A detailed history of Bank Of America Corp transactions in Glaukos Corp stock. As of the latest transaction made, Bank Of America Corp holds 319,470 shares of GKOS stock, worth $40.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
319,470
Previous 290,000 10.16%
Holding current value
$40.5 Million
Previous $27.3 Million 38.27%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $2.64 Million - $3.49 Million
29,470 Added 10.16%
319,470 $37.8 Million
Q1 2024

May 15, 2024

SELL
$76.4 - $96.33 $6.22 Million - $7.84 Million
-81,354 Reduced 21.91%
290,000 $27.3 Million
Q4 2023

Feb 14, 2024

SELL
$59.53 - $85.11 $2.15 Million - $3.08 Million
-36,182 Reduced 8.88%
371,354 $29.5 Million
Q2 2023

Aug 14, 2023

SELL
$45.44 - $71.21 $2.08 Million - $3.26 Million
-45,739 Reduced 10.09%
407,536 $29 Million
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $4.78 Million - $5.71 Million
108,839 Added 31.6%
453,275 $22.7 Million
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $791,173 - $1.12 Million
-19,382 Reduced 5.33%
344,436 $15 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $1.77 Million - $2.2 Million
37,693 Added 11.56%
363,818 $19.4 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $3.11 Million - $5.7 Million
-89,332 Reduced 21.5%
326,125 $14.8 Million
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $1.59 Million - $2.08 Million
35,931 Added 9.47%
415,457 $24 Million
Q4 2021

Feb 08, 2022

BUY
$40.27 - $56.99 $1.1 Million - $1.56 Million
27,302 Added 7.75%
379,526 $16.9 Million
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $2.49 Million - $4.43 Million
52,557 Added 17.54%
352,224 $17 Million
Q2 2021

Sep 13, 2021

BUY
$73.06 - $97.7 $21.9 Million - $29.3 Million
299,667 New
299,667 $25.4 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.03B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.